Plants as sources of anti-inflammatory agents

CR Nunes, M Barreto Arantes… - Molecules, 2020 - mdpi.com
Plants represent the main source of molecules for the development of new drugs, which
intensifies the interest of transnational industries in searching for substances obtained from …

Stereoselective synthesis and applications of spirocyclic oxindoles

AJ Boddy, JA Bull - Organic Chemistry Frontiers, 2021 - pubs.rsc.org
The development of novel synthetic strategies to form new chemical entities in a
stereoselective manner is an ongoing significant objective in organic and medicinal …

An overview of spirooxindole as a promising scaffold for novel drug discovery

LM Zhou, RY Qu, GF Yang - Expert Opinion on Drug Discovery, 2020 - Taylor & Francis
Introduction: Spirooxindole, a unique and versatile scaffold, has been widely studied in
some fields such as pharmaceutical chemistry and synthetic chemistry. Especially in the …

Recent strategies in the synthesis of spiroindole and spirooxindole scaffolds

S Nasri, M Bayat, F Mirzaei - Topics in Current Chemistry, 2021 - Springer
Spiroindole and spirooxindole scaffolds are very important spiro-heterocyclic compounds in
drug design processes. Significant attention has been directed at obtaining molecules …

The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy

Y Liu, X Wang, G Wang, Y Yang, Y Yuan… - European journal of …, 2019 - Elsevier
The p53 gene, a well-known tumor suppressor gene, plays a crucial role in cell cycle
regulation, DNA repair, cell differentiation, and apoptosis. MDM2 exerts p53-dependent …

Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review)

AA Bhat, I Singh, N Tandon, R Tandon - European Journal of Medicinal …, 2023 - Elsevier
Pyrrolidine molecules are a significant class of synthetic and natural plant metabolites,
which show the diversity of pharmacological activities. An extensive variety of synthetic …

Design, synthesis, chemical and biochemical insights into novel hybrid spirooxindole-based p53-MDM2 inhibitors with potential Bcl2 signaling attenuation

YMA Aziz, G Lotfy, MM Said, ESH El Ashry… - Frontiers in …, 2021 - frontiersin.org
The tumor resistance to p53 activators posed a clinical challenge. Combination studies
disclosed that concomitant administration of Bcl2 inhibitors can sensitize the tumor cells and …

[HTML][HTML] Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors

M Espadinha, EA Lopes, V Marques, JD Amaral… - European Journal of …, 2022 - Elsevier
MDM2 and MDM4 are key negative regulators of p53, an important protein involved in
several cell processes (eg cell cycle and apoptosis). Not surprisingly, the p53 tumor …

Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next …

G Lotfy, YMA Aziz, MM Said, H El Sayed, H El Sayed… - Bioorganic …, 2021 - Elsevier
Despite the achieved progress in develo** efficient MDM2-p53 protein-protein interaction
inhibitors (MDM2 inhibitors), the acquired resistance of tumor cells to such p53 activators …

p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies

R Bhatia, B Kumar - European Journal of Medicinal Chemistry, 2023 - Elsevier
Cancer represents one of the world's biggest hazardous diseases. p53 is the uttermost
researched tumour suppressor protein. It is commonly considered the “guardian of the …